hotspot -WSS

hotspot

author：leisure time 2025-10-02 01:07:22 - browse：93

A pile of Zynex Medical batteries and electrode pads are seen at Michelle Bean's home — A pile of Zynex Medical batteries and electrode pads Kayana Szymczak for STAT

Sending patients heaps of medical supplies to score more money from insurers is common in the device industry. If insurers decline to cover the supplies, patients are stuck paying for materials they didn’t need.

STAT examined one of the companies perpetuating this practice, a pain management device company called Zynex Medical, and the frustration among both its patients and former employees. Here are five takeaways.

The ‘razor blade’ business model

Zynex sells nerve and muscle stimulation machines, known as TENS and EMS units, to treat pain and soothe muscles. But the company makes most of its money from monthly shipments of batteries and electrodes — almost 70% of its $184 million revenue in 2023 came from these supplies.

STAT+ Exclusive Story

Already have an account? Log in

This article is exclusive to STAT+ subscribers

Unlock this article — and get additional analysis of the technologies disrupting health care — by subscribing to STAT+.

Already have an account? Log in

Monthly

$39

Totals $468 per year

$39/month Get Started

Totals $468 per year

Starter

$30

for 3 months, then $39/month

$30 for 3 months Get Started

Then $39/month

Annual

$399

Save 15%

$399/year Get Started

Save 15%

11+ Users

Custom

Savings start at 25%!

Request A Quote Request A Quote

Savings start at 25%!

2-10 Users

$300

Annually per user

$300/year Get Started

$300 Annually per user

View All Plans

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Jerome Adams on the need for new antivirals for Covid
Next article： Security flaws in third

Wikipedia

knowledge

WSS

Drug cartel violence flares in western Mexico after vigilante leader's killing

The future of Biogen: Pragmatism, ‘moonshots,’ and no Twinkies

Study on Amgen’s bispecific immunotherapy produces positive data

Crowdfunding for unproven stem cell procedures spreads misinformation

Drug cartel violence flares in western Mexico after vigilante leader's killing

What affirmative action's end means to a medical student

hotspot

hotspot

The ‘razor blade’ business model

This article is exclusive to STAT+ subscribers

Unlock this article — and get additional analysis of the technologies disrupting health care — by subscribing to STAT+.

explore

The cancer drug shortage isn’t new — and neither are the solutions

STAT Summit: How researchers deal with rejection

Medicare details structure of new drug price negotiation program

Being 'nonadherent' patient made me a more empathetic doctor

How one medical school became remarkably diverse

Why a market frenzy over new weight loss drugs defies logic

George Santos makes 1st court appearance after pleading not guilty to 13 counts

The wait for US passports is creating travel purgatory and snarling summer plans

Medicare details structure of new drug price negotiation program

UnitedHealth, Optum discontinue NaviHealth name

hotspot

STAT Readout Newsletter: Biotech news today

STAT Summit: Meghan O’Rourke on making chronic illness visible

STAT Summit: The economic case for universal basic health care

Security flaws in third

Canadians with cystic fibrosis outlive Americans by a decade

What affirmative action's end means to a medical student

Wikipedia

knowledge

focus

knowledge